Special Issue "Biophotonics for COVID-19 Diagnosis and Treatment"

A special issue of Photonics (ISSN 2304-6732). This special issue belongs to the section "Biophotonics and Biomedical Optics".

Deadline for manuscript submissions: closed (31 January 2022) | Viewed by 813

Special Issue Editors

Prof. Dr. Valentina Quaresima
E-Mail Website
Guest Editor
Department of Life, Health and Environmental Sciences, Università degli Studi dell'Aquila, L'Aquila, Italy
Interests: biomedical optics; tissue oximetry; functional near infrared spectroscopy
Prof. Dr. Turgut Durduran
E-Mail Website
Guest Editor
ICFO-The Institute of Photonic Sciences, Barcelona, Spain
Interests: diffuse optics; diffuse correlation spectroscopy; near-infrared spectroscopy; clinical applications
Prof. Dr. Benjamin L. Miller
E-Mail Website
Guest Editor
Department of Dermatology, University of Rochester, Rochester, NY 14642, USA
Interests: integrated photonic sensors; lab-on-a-chip systems; diagnostics for the developing world
Special Issues, Collections and Topics in MDPI journals
Prof. Alessandro Torricelli
E-Mail Website
Guest Editor
Department of Physics, Politecnico di Milano, Milan, Italy
Interests: Biomedical optics; time domain tissue oximetry; time domain functional near infrared spectroscopy

Special Issue Information

Dear Colleagues,

Since beginning in December 2019, the COVID-19 pandemic has spread over the world. The Biophotonics community has rapidly responded with innovative biomedical optics technologies helping in the fight against COVID-19.

The purpose of this Special Issue is to highlight these innovative approaches to addressing COVID-19 with Biophotonics. We invite original research articles and state-of-the-art reviews focused on current knowledge and future perspectives of Biophotonics for COVID-19 diagnosis, management, and treatment.

The overall goal of the issue is to highlight the versatility of Biophotonics for responding to new health challenges with direct clinical implications.

Topics include:

  1. Innovative Biophotonics technologies helping in the fight against COVID-19
  2. Optical methods for quantifying the immune response to SARS-CoV-2
  3. Fast and reliable diagnostic tools
  4. New optical wearables for COVID-19
  5. New developments in pulse oximetry
  6. Diffuse optics for the evaluation of microvascular and endothelial health of different tissues
  7. Photonics industry responses to COVID-19
Prof. Dr. Valentina Quaresima
Prof. Turgut Durduran
Prof. Dr. Benjamin L. Miller
Prof. Alessandro Torricelli
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Photonics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop